---
figid: PMC8087246__fphar-12-618172-g002
figtitle: Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast
  Cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Staphylococcus aureus
- Zingiber officinale
- Levilactobacillus brevis
- Pyracantha fortuneana
- Homo sapiens
- Sus scrofa
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8087246
filename: fphar-12-618172-g002.jpg
figlink: /pmc/articles/PMC8087246/figure/F2/
number: F2
caption: 'Action of Methylseleninic acid and Selenocysteine on oncogenic pathways.
  Inhibition of PI3K and RAS proteins by MCS halts the activation of transcription
  factors (S6KT and 4EBP) and MAPK pathway which is essential for the activation of
  cell cycle regulatory genes. Whereas, MSA down-regulates the PII and I.4 promoters
  of the aromatase gene leading to the formation of inadequate levels of estrogen.
  The action of MCS and MSA on their respective targets helps in the prevention of
  cancer cell growth, proliferation, differentiation, migration, and induces apoptosis.
  Abbreviations: 4EBP, Eukaryotic Translation initiation factor 4E binding protein;
  CYP19A2, Cytochrome P450 Aromatase; ER, Estrogen receptor protein; ERE, Estrogen
  responsive element; IRS-1, Insulin receptor substrate; JAK, Janus kinase; MAPK,
  Mitogen-activated protein kinase; MCS, Methylselenocysteine; MEK, Mitogen-activated
  protein kinase; mTOR, Mammalian target of rapamycin; MSA, Methylseleninic acid;
  PI3K: Phosphoinositide 3-kinase; RAF, Rapidly Accelerated Fibrosarcoma; RAS, Rat
  sarcoma; ROS, Reactive oxygen species; S6KT, Ribosomal protein S6 kinase beta-1;
  Stat, signal transducer and activator of transcription.'
papertitle: Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast
  Cancer.
reftext: Supriya Bevinakoppamath, et al. Front Pharmacol. 2021;12:618172.
year: '2021'
doi: 10.3389/fphar.2021.618172
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: obesity | breast cancer | selenoprotein | organoselenium compound | oxidative
  stress
automl_pathway: 0.9055852
figid_alias: PMC8087246__F2
figtype: Figure
redirect_from: /figures/PMC8087246__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8087246__fphar-12-618172-g002.html
  '@type': Dataset
  description: 'Action of Methylseleninic acid and Selenocysteine on oncogenic pathways.
    Inhibition of PI3K and RAS proteins by MCS halts the activation of transcription
    factors (S6KT and 4EBP) and MAPK pathway which is essential for the activation
    of cell cycle regulatory genes. Whereas, MSA down-regulates the PII and I.4 promoters
    of the aromatase gene leading to the formation of inadequate levels of estrogen.
    The action of MCS and MSA on their respective targets helps in the prevention
    of cancer cell growth, proliferation, differentiation, migration, and induces
    apoptosis. Abbreviations: 4EBP, Eukaryotic Translation initiation factor 4E binding
    protein; CYP19A2, Cytochrome P450 Aromatase; ER, Estrogen receptor protein; ERE,
    Estrogen responsive element; IRS-1, Insulin receptor substrate; JAK, Janus kinase;
    MAPK, Mitogen-activated protein kinase; MCS, Methylselenocysteine; MEK, Mitogen-activated
    protein kinase; mTOR, Mammalian target of rapamycin; MSA, Methylseleninic acid;
    PI3K: Phosphoinositide 3-kinase; RAF, Rapidly Accelerated Fibrosarcoma; RAS, Rat
    sarcoma; ROS, Reactive oxygen species; S6KT, Ribosomal protein S6 kinase beta-1;
    Stat, signal transducer and activator of transcription.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Smcp
  - Mocos
  - Irs1
  - Mtor
  - Zhx2
  - Mdk
  - ras
  - Hras
  - Kras
  - Rem1
  - ap
  - Apk
  - Exo1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMCP
  - MOCOS
  - ZC4H2
  - IRS1
  - BTK
  - MTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - HRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - TPO
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - atk
  - Tor
  - Thor
  - Raf
  - Dsor1
  - Mtk
  - MKP-4
  - p38b
  - rl
  - Ras64B
  - Ras85D
  - Nplp1
  - hop
  - bsk
  - lncRNA:iab8
  - Stat92E
  - CycE
  - cyc
---
